BIOCYTOGEN
Biocytogen is a clinical stage biopharmaceutical company that integrates proprietary gene editing technology, transgenic mouse platforms to generate fully human antibodies, comprehensive animal models and high-throughput in vivo antibody discovery. We have established fully integrated research and development capabilities ranging from early target discovery to clinical development. Our focus on research and development and technological innovation serves as the cornerstone of our continuing growth. We intend to develop and commercialize first-in-class or best-in-class drugs to contribute to the improvement of human health worldwide.
BIOCYTOGEN
Social Links:
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2008-11-01
Status:
Active
Contact:
781-587-3558
Email Addresses:
[email protected]
Total Funding:
335.15 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Person Schema Google Google Cloud Cloudflare Hosting Facebook Sharer Gravatar Profiles SiteXpress
Similar Organizations
SyMap Medical
SyMap Medical is an innovative medical device company.
Current Employees Featured
Founder
Stock Details
Investors List
Remegen
Remegen investment in Post-IPO Equity - Biocytogen
Veken Technology
Veken Technology investment in Post-IPO Equity - Biocytogen
OrbiMed
OrbiMed investment in Series E - Biocytogen
CPE
CPE investment in Series E - Biocytogen
Octagon Capital Partners
Octagon Capital Partners investment in Series E - Biocytogen
Lake Bleu Capital
Lake Bleu Capital investment in Series E - Biocytogen
CMB International Capital Corporation
CMB International Capital Corporation investment in Series D - Biocytogen
China Life Healthcare Fund
China Life Healthcare Fund investment in Series D - Biocytogen
Cowin Capital
Cowin Capital investment in Series D - Biocytogen
3E Bioventures
3E Bioventures investment in Series D - Biocytogen
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Doma Biopharmaceutical | Biocytogen investment in Series A - Doma Biopharmaceutical | 950 M CNY |
More informations about "Biocytogen"
About Us | Biocytogen
Biocytogen provides integrated solutions for next-generation antibody drug development to the global biomedical communities.See details»
Biocytogen Completes a New Round of Financing โฆ
BEIJING and BOSTON, June 22, 2021- Biocytogen, an international biotechnology company focused on antibody drug research and development using innovative genetically engineered animal models, today announced the โฆSee details»
Biocytogen - Crunchbase Investor Profile & Investments
Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development. View contacts for Biocytogen to access new leads and connect with decision โฆSee details»
Biocytogen - The Org
Biocytogen is a preclinical stage biotech that provides a one-stop solution for antibody discovery from target to IND application.See details»
Biocytogen Pharmaceuticals (Beijing) Co., โฆ
Beijing, China, May 6, 2024 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (โBiocytogenโ, HKEX: 02315), a global biotechnology company focused on the discovery of novel antibody-based therapeutics, today announced a TCR โฆSee details»
Biocytogen - Funding, Financials, Valuation & Investors - Crunchbase
Biocytogen is registered under the ticker HKG:02315 . Their stock opened with HK$25.22 in its Sep 1, 2022 IPO. Stock Symbol HKG:02315 ; Valuation at IPO $357M; Money Raised at IPO โฆSee details»
Biocytogen Completes a New Round of Financing Totaling Tens of โฆ
Jun 22, 2021 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. was established in 2009. ... With the implementation of these platforms, Biocytogen has evolved from a contract research โฆSee details»
TEST|BioMice๏ฝBiocytogen
Beijing, China, [September 28th], 2021 โ Biocytogen announces a collaboration with Envigo, a global organization offering the broadest range of research models and related services. The โฆSee details»
Biocytogen Announces Collaboration With Envigo To โฆ
Sep 28, 2021 Biocytogen is a global biotech company that drives the research and development of new drugs with innovative technologies. The company is committed to becoming a global headstream of new drugs and bringing โฆSee details»
Biocytogen - Products, Competitors, Financials, Employees, โฆ
Biocytogen operates as a preclinical contract research organization (CRO) in the biomedical sector, focusing on antibody drug development. The company provides services such as gene โฆSee details»
Biocytogen and Gilead Enter Into a Multi-Target Antibody โฆ
Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the โฆSee details»
Biocytogen Announces Collaboration With Envigo To Distribute
Sep 28, 2021 /CNW/ -- Biocytogen announces a collaboration with Envigo, a global organization offering the broadest range of research models and related services. The two...See details»
In Vivo Models, Animal Models for Research | Biocytogen
Biocytogen is a one-stop CRO that provides humanized mouse models for immuno-oncology and autoimmune/inflammatory disease targets, which can help move projects from target to IND โฆSee details»
Pheon Therapeutics enters into license agreement with Biocytogen ...
Jul 5, 2023 Exclusive license agreement for an oncological target antibody to develop best-in-class ADC. London, UK and Beijing, China, 5 July 2023 โ Pheon Therapeutics (Pheon), a โฆSee details»
Biocytogen Completes a New Round of Financing Totaling Tens
Jun 22, 2021 /CNW/ -- Biocytogen, an international biotechnology company focused on antibody drug research and development ... Organization Profile. Biocytogen. Contact Cision. 866-245 โฆSee details»
Biocytogen announces collaboration with Envigo to distribute the โฆ
Biocytogen is a global biotech company that drives the research and development of new drugs with innovative technologies. The company is committed to becoming a global headstream of โฆSee details»
Join BIOCYTOGEN at Society for Immunotherapy of Cancer 2024
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies.See details»
Biocytogen Expands Global Footprint with the Opening of โฆ
Mar 28, 2022 About Biocytogen Biocytogen Pharmaceuticals (Beijing) Co., Ltd. is a global biotechnology company that drives the research and development of novel antibody-based โฆSee details»
Pipeline - Biocytogen
Biocytogen is dedicated to the discovery and development of novel antibody-based drugs to meet unmet medical needs, with a particular focus on oncology, autoimmune, inflammatory, โฆSee details»